Chat about Oxford Biomedica accounts information. See how Oxford Biomedica is performing financially.

Oxford Biomedica Accounts Summary


Date of Accounts 20252024202320222021
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement31-12-202531-12-202431-12-202331-12-202231-12-2021
Revenue168.74128.8089.54139.99142.80
Operating Profit / Loss-22.48-39.38-184.17-30.2220.77
Net Interestn/an/a-14.17-15.76-0.89
Pre Tax Profit-31.94-47.27-188.53-45.9819.88
Post Tax Profit-30.64-48.61-184.16-45.1619.01
Profit for the Period-30.65-48.61-184.16-45.1619.01
Equity Holders of Parent Company-30.13-43.19-157.49-39.1619.01
Minority Interests-0.52-5.42-26.67-6.00n/a
      
Continuing EPS     
Earnings per Share (Basic)-26.92p-41.75p-163.11p-41.29p22.77p
Earnings per Share (Diluted)-26.92p-41.75p-163.11p-41.29p22.20p
Earnings per Share (Adjusted)-26.92p-41.75p-163.11p-41.29p22.77p
Continuing and Discontinued EPS     
Earnings per Share (Basic)-26.92p-41.75p-163.11p-41.29p22.77p
Earnings per Share (Diluted)-26.92p-41.75p-163.11p-41.29p22.20p
Earnings per Share (Adjusted)-26.92p-41.75p-163.11p-41.29p22.77p
      
Dividend per Sharen/apn/apn/apn/apn/ap
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet31-12-202531-12-202431-12-202331-12-202231-12-2021
Non-Current Assets     
Intangible Assets25.1729.2230.98105.890.05
Property, Plant and Equipment107.6364.3075.69133.7869.73
Investmentsn/an/an/an/an/a
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assets7.284.934.345.013.61
Total Non-Current Assets140.0798.45111.01244.6873.39
      
Current Assets     
Inventories17.3313.5712.8712.629.52
Trade and Other Receivables71.2758.9724.7461.5944.75
Cash at Bank and in Hand96.8860.65103.72141.28108.94
Current Asset Investmentsn/an/an/an/an/a
Other Current Assets0.17n/an/an/a0.63
Total Current Assets185.65133.19141.33215.50163.84
      
Other Assetsn/an/an/an/an/a
Total Assets325.72231.64252.34460.18237.23
      
Current Liabilities     
Borrowings6.064.423.653.300.85
Other Current Liabilities78.1653.9040.6656.3732.45
Total Current Liabilities84.2258.3244.3159.6633.31
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings142.07104.34107.80110.998.49
Provisions7.397.428.5514.016.24
Other Non-Current Liabilities0.691.0713.8439.331.85
Total Non-Current Liabilities150.15112.84130.19164.3216.58
      
Net Assets91.3560.4977.83236.19187.34
      
Capital and Reserves     
Share Capital60.3852.9848.4048.1343.09
Share Premium Account445.85394.86380.33379.95307.77
Other Reserves7.478.71-1.81-24.892.29
Retained Earnings-422.35-399.50-352.92-198.54-165.81
Shareholders Funds91.3557.0574.01204.65187.34
      
Minority Interests / Other Equityn/a3.443.8331.54n/a
Total Equity91.3560.4977.83236.19187.34
      
 31-12-202531-12-202431-12-202331-12-202231-12-2021
Operating Margin-13.32%-30.57%-205.69%-21.59%14.54%
Return on Capital Employed-14.41%-32.05%-104.49%-11.69%10.24%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/an/an/an/a54.00
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share54.75p25.87p38.76p107.80p154.94p